3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 24.55
-0.15 (-0.61%)
Jun 18, 2026, 2:59 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 1.89 billion as of June 18, 2026. Its market cap has decreased by -55.86% in one year.
Market Cap
1.89B
Enterprise Value
1.46B
Revenue
206.74M
Ranking
n/a
PE Ratio
29.23
Stock Price
24.55
Market Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has decreased from 2.74B to 1.89B, a decrease of -30.93%. That is a compound annual growth rate of -6.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.89B | -49.73% |
| Dec 31, 2025 | 3.76B | -26.72% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taiwan Bio Therapeutics | 2.18B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.07B |
| G&E Herbal Biotechnology | 2.00B |
| Sunhawk Vision Biotech | 2.00B |
| Sunny Pharmtech | 1.99B |
| Greenyn Biotechnology | 1.82B |
| Synbio Tech | 1.74B |
| Great Novel Therapeutics Biotech & Medicals | 1.64B |